Fox Chase Cancer Center News

PHILADELPHIA (August 10, 2020)—In a recent study, researchers at Fox Chase Cancer Center found that prostate tumor growth was delayed in mouse models when treated with specific types of radiodynamic therapy.

PHILADELPHIA (August 6, 2020) - As part of its never-ending commitment to community health, Fox Chase Cancer Center proudly supports Miles for Melanoma 2020 in Philadelphia. The Melanoma Research Foundation is adhering to social distancing guidelines and making the 5k run/walk virtual this year.

PHILADELPHIA (August 5, 2020)—In a study published online today, researchers from Fox Chase Cancer Center and Temple University used a novel approach to analyzing cancer survival disparities in relation to residence by incorporating residential mobility.

PHILADELPHIA (August 4, 2020)–Physicians at Fox Chase Cancer Center have published an editorial outlining how they conducted virtual recruiting interviews for their surgical oncology fellowships, a publication they say is one of the first of its kind.

PHILADELPHIA (July 29, 2020)—Researchers at Fox Chase Cancer Center have determined that the protein NeuroD1 promotes cell differentiation in medulloblastoma, a finding that could help researchers develop novel cancer treatments.

PHILADELPHIA (July 28, 2020) – Fox Chase Cancer Center announces the hiring of Elizabeth A. Bourne, DO, who will join the Department of Medicine as an assistant professor in the Division of Hospitalist Medicine.

PHILADELPHIA (July 27, 2020)—Researchers at Fox Chase Cancer Center found in a recent study that older patients who underwent chemoradiation therapy followed by removal of their esophagus due to cancer had toxicities and outcomes similar to younger patients.

PHILADELPHIA (July 27, 2020)—In a recent review article, Fox Chase Cancer Center researchers outlined obstacles, research methods, and future treatment prospects for patients with Von Hippel-Lindau (VHL) disease.